SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Nakamura H, Kawasaki N, Hagiwara M, et al. Early hilar lung cancer—risk for multiple lung cancers and clinical outcome. Lung Cancer. 2001; 33: 51-57.
  • 2
    Warren W, Faber P. Segmentectomy versus lobectomy in patients with stage I pulmonary carcinoma. J Thorac Cardiovasc Surg. 1994; 107: 1087-1094.
  • 3
    Ginsberg RJ, Rubinstein LV. Randomized trial of lobectomy versus limited resection for T1N0 non-small cell lung cancer. Ann Thorac Surg. 1995; 60: 615-621.
  • 4
    Kodama K, Doi O, Higashiyama M, et al. Intentional limited resection for selected patients with T1N0M0 nonsmall-cell lung cancer: a single-institution study. J Thorac Cardiovasc Surg. 1997; 114: 347-353.
  • 5
    Yoshikawa K, Tsubota N, Kodama K, et al. Prospective study of extended segmentectomy for small lung tumors: the final report. Ann Thorac Surg. 2002; 73: 1055-1058.
  • 6
    Okada M, Yoshikawa K, Hatta T, et al. Is segmentectomy with lymph node assessment an alternative to lobectomy for non-small lung cancer of 2 cm or smaller? Ann Thorac Surg. 2001; 7: 956-960.
  • 7
    Santos R, Colonias A, Parda D, et al. Comparison between sublobar resection and 125 I brachytherapy following sublobar resection in high-risk patients with stage 1 non-small cell lung cancer. Surgery. 2003; 134: 691-697.
  • 8
    Lee W, Daly BD, DiPetrillo TA, et al. Limited resection for non-small cell lung cancer: observed local recurrence with implantation of I-125 brachytherapy seeds. Ann Thorac Surg. 2003; 75: 237-242.
  • 9
    Shennib H, Bogart JA, Herndon J, et al. Thoracoscopic wedge resection and radiotherapy for T1N0 non-small lung cancer: preliminary analysis of a Cancer and Leukemia Group B and Eastern Oncology Group phase II trial [abstract]. Int J Radiat Oncol Biol Phys. 2000; 48( 3 suppl): 232. Abstract 240.
  • 10
    Cackler S, Abbas G. RFA is an effective alternative to lobectomy for lung cancer. JAAPA. 2009; 22: 25-28.
  • 11
    Blomgren H, Lax I, Naslund I, Svanstrom R. Stereotactic high dose fraction radiation therapy of extracranial tumours using an accelerator. Acta Oncol. 1995; 34: 861-870.
  • 12
    Powell JW, Dexter E, Scalzetti EM, et al. Treatment advances for medically inoperable non-small-cell lung cancer: emphasis on prospective trials. Lancet Oncol. 2009; 10: 885-894.
  • 13
    American Association of Physicists in Medicine (AAPM) Radiation Therapy Committee Task Group 43. Dosimetry of Interstitial Brachytherapy Sources: Report TG 43. College Park, Md: AAPM; 1995.
  • 14
    Keenan RJ, Landreneau RJ, Maley RH Jr, et al. Segmental resection spares pulmonary function in patients with stage I lung cancer. Ann Thorac Surg. 2004; 78: 228.
  • 15
    Harada H, Okada M, Sakamoto T, et al. Functional advantage after radical segmentectomy versus lobectomy for lung cancer. Ann Thorac Surg. 2005; 80: 2041-2045.
  • 16
    Yoshimoto K, Nomori H, Mori T, et al. Quantification of the impact of segmentectomy on pulmonary function by perfusion single-photon-emission computed tomography and multidetector computed tomography. J Thorac Cardiovasc Surg. 2009; 137: 1200-1205.
  • 17
    Lafitte JJ, Ribet ME, Prevost BM, et al. Postresection irradiation for T2 N0 M0 non-small cell carcinoma: a prospective, randomized study. Ann Thorac Surg. 1996; 62: 830-834.
  • 18
    Feld R, Rubinstein LV, Weisenberger TH. Sites of recurrence in resected stage I non-small-cell lung cancer: a guide for future studies. J Clin Oncol. 1984; 2: 1352-1358.
  • 19
    Kato H, Ichinose Y, Ohta M, et al. A randomized trial of adjuvant chemotherapy with uracil-tegafur for adenocarcinoma of the lung. N Engl J Med. 2004; 350: 1713-1721.
  • 20
    Lardinois D, Suter H, Hakki H, et al. Morbidity, survival, and site of recurrence after mediastinal lymph-node dissection versus systematic sampling after complete resection for non-small cell lung cancer. Ann Thorac Surg. 2005; 80: 268-274; discussion 274-275.
  • 21
    Harpole DHJr, Herndon JEJr, Young WGJr, et al. Stage I nonsmall cell lung cancer. A multivariate analysis of treatment methods and patterns of recurrence. Cancer. 1995; 76: 787-796.
  • 22
    Martini N, Bains MS, Burt ME, et al. Incidence of local recurrence and second primary tumors in resected stage I lung cancer. J Thorac Cardiovasc Surg. 1995; 109: 120-129.
  • 23
    Immerman SC, Vanecko RM, Fry WA, et al. Site of recurrence in patients with stages I and II carcinoma of the lung resected for cure. Ann Thorac Surg. 1981; 32: 23-27.
  • 24
    Onishi H, Shirato H, Nagata Y, et al. Hypo-fractionated stereotactic radiotherapy (HypoFXSRT) for stage I non-small cell lung cancer: updated results of 257 patients in a Japanese multi-institutional study. J Thorac Oncol. 2007; 2: 94-100.
  • 25
    Xiao L, Li Z, Wu L, Sun Z, Yu X. Sequential treatment of superior vena cava syndrome caused by of non-small cell carcinoma lung cancer (NSCLC) with vascular stenting and iodine-125 implantation. Technol Cancer Res Treat. 2009; 8: 281-287.
  • 26
    Zhang FJ, Li CX, Wu PH, et al. CT guided radioactive 125I seed implantation in treating localized advanced pulmonary carcinoma [in Chinese]. Zhonghua Yi Xue Za Zhi. 2007; 87: 3272-3275.
  • 27
    Trombetta MG, Colonias A, Makishi D, et al. Tolerance of the aorta using intraoperative iodine-125 interstitial brachytherapy in cancer of the lung. Brachytherapy. 2008; 7: 50-54.
  • 28
    Peters N, Wieners G, Pech M, et al. CT-guided interstitial brachytherapy of primary and secondary lung malignancies: results of a prospective phase II trial. Strahlenther Onkol. 2008; 184: 296-301.
  • 29
    Martinez-Monge R, Pagola M, Vivas I, et al. CT-guided permanent brachytherapy for patients with medically inoperable early stage non-small cell lung cancer (NSCLC). Lung Cancer. 2008; 61: 209-213.
  • 30
    McKenna RJ Jr, Mahtabifard A, Yap J, et al. Wedge resection and brachytherapy for lung cancer in patients with poor pulmonary function. Ann Thorac Surg. 2008; 85: S733-S736.